| COINOTAG recommends • Exchange signup |
| 💹 Trade with pro tools |
| Fast execution, robust charts, clean risk controls. |
| 👉 Open account → |
| COINOTAG recommends • Exchange signup |
| 🚀 Smooth orders, clear control |
| Advanced order types and market depth in one view. |
| 👉 Create account → |
| COINOTAG recommends • Exchange signup |
| 📈 Clarity in volatile markets |
| Plan entries & exits, manage positions with discipline. |
| 👉 Sign up → |
| COINOTAG recommends • Exchange signup |
| ⚡ Speed, depth, reliability |
| Execute confidently when timing matters. |
| 👉 Open account → |
| COINOTAG recommends • Exchange signup |
| 🧭 A focused workflow for traders |
| Alerts, watchlists, and a repeatable process. |
| 👉 Get started → |
| COINOTAG recommends • Exchange signup |
| ✅ Data‑driven decisions |
| Focus on process—not noise. |
| 👉 Sign up → |
Windtree Therapeutics received a Nasdaq notice on August 19, 2025 under Rule 5550(a)(2) after its share price remained below $1. Following multiple reverse stock splits and failure to satisfy extension criteria, the company’s common stock will be delisted from the Nasdaq Capital Market on August 21 and transition to the OTC market; shares closed down 77.21% today, leaving a reported market cap of $3.152 million.
WINT has registered a pronounced multi-period decline: the share price was $517.50 on August 22 last year (a drop of ~99.98% year-over-year), and opened at $4.68 on February 21 before falling ~97.8% since. After announcing the BNB Treasury strategy, trading volume spiked and the stock briefly reached $1.28 on July 18 prior to a subsequent decline of ~91.4%.
The company remains clinical-stage with several pre-commercial programs; latest reported net revenue was –$10.64 million versus –$4.04 million in the prior quarter (losses up ~163.04%). In July, Windtree disclosed a $60 million securities subscription and a separate $520 million financing agreement to acquire BNB.
| COINOTAG recommends • Members‑only research |
| 📌 Curated setups, clearly explained |
| Entry, invalidation, targets, and R:R defined before execution. |
| 👉 Get access → |
| COINOTAG recommends • Members‑only research |
| 🧠 Data‑led decision making |
| Technical + flow + context synthesized into actionable plans. |
| 👉 Join now → |
| COINOTAG recommends • Members‑only research |
| 🧱 Consistency over hype |
| Repeatable rules, realistic expectations, and a calmer mindset. |
| 👉 Get access → |
| COINOTAG recommends • Members‑only research |
| 🕒 Patience is an edge |
| Wait for confirmation and manage risk with checklists. |
| 👉 Join now → |
| COINOTAG recommends • Members‑only research |
| 💼 Professional mentorship |
| Guidance from seasoned traders and structured feedback loops. |
| 👉 Get access → |
| COINOTAG recommends • Members‑only research |
| 🧮 Track • Review • Improve |
| Documented PnL tracking and post‑mortems to accelerate learning. |
| 👉 Join now → |
